B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SGK1

MOLECULAR TARGET

serum/glucocorticoid regulated kinase 1

UniProt: O00141NCBI Gene: 64464 compounds

SGK1 (serum/glucocorticoid regulated kinase 1) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SGK1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1gsk 6503942.208
2uprosertib1.956
3Resveratrol1.102
4sp6001250.691

About SGK1 as a Drug Target

SGK1 (serum/glucocorticoid regulated kinase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented SGK1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SGK1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.